Initial Therapeutics is based in South San Francisco, California. It has raised $187M in total funding. Latest round: IPO.
Initial Therapeutics funding overview
Initial Therapeutics is based in South San Francisco, California. Initial Therapeutics has raised $187M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is an IPO announced in September 2021. The round record for Initial Therapeutics runs through 2021; nothing later has been disclosed. Investors on record include Agent Capital, Northpond Ventures, Alexandria Venture Investments. 3 distinct backers are named across the disclosed rounds.
Frequently asked about Initial Therapeutics funding
How much has Initial Therapeutics raised?
Initial Therapeutics has raised $187M in total disclosed funding across the rounds on record.
Who has invested in Initial Therapeutics?
Agent Capital, Northpond Ventures, Alexandria Venture Investments are named among the investors backing Initial Therapeutics.
What was the latest Initial Therapeutics funding round?
The most recent disclosed round is an IPO, announced in September 2021.
Where is Initial Therapeutics based?
Initial Therapeutics is based in South San Francisco, California.
When did Initial Therapeutics last raise?
The last disclosed Initial Therapeutics round closed in September 2021 at IPO.
Totals shown for Initial Therapeutics aggregate every disclosed round on file. To see how that compares, browse the companies in South San Francisco and the investors behind them below.
